Dr. Juan Camilo Arjona Ferreira - 04 Jan 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Medical Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
04 Jan 2022
Net transactions value
-$36,949
Form type
4
Filing time
06 Jan 2022, 15:21:06 UTC
Previous filing
01 Dec 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $36,949 -2,271 -1.4% $16.27 164,342 04 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.